Ipilimumab
Summary
Ipilimumab is a human monoclonal antibody.
Risk. The use of amino acids, proteins and peptides is not considered to have any environmental impact.
This summary information comes from fass.se.
Detailed information
Fass environmental information
Fass environmental information for Yervoy (ipilimumab) from Bristol-Myers Squibb (retrieved on 2025-07-09).
According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.
References
Author: Health and Medical Care Administration, Region Stockholm